Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Prophylactic Treatment With Atorvastatin for Episodic Migraine. [Phase 2]

View source ↗

Summary

Phase 2 trial to evaluate prophylactic atorvastatin for episodic migraine is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Episodic Migraine | Phase 2 | Status: RECRUITING